Table 3.
Clinical characteristics and current use of prednisone, methotrexate, and biological agents in the QUEST-RA study
| Country | Sites | Patients | Female (%) | Age (years) | Disease duration (years) | DMARD delay (months) | Education (years) | RF+ (%) | DAS 28 | HAQ | Taking now (%) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pred | MTX | Any biological | |||||||||||
| Mean | Mean | Median | Median | Median | Median | ||||||||
| Netherlands | 3 | 317 | 66.3 | 59.2 | 9.2 | 5.5 | 11.0 | 68.8 | 2.9 | 0.8 | 16.1 | 74.1 | 19.6 |
| Greece | 3 | 300 | 75.7 | 57.9 | 11.8 | 7.0 | 12.0 | 52.1 | 3.1 | 0.3 | 70.7 | 71.3 | 47.0 |
| Finland | 3 | 304 | 72.4 | 58.5 | 13.5 | 7.0 | 9.0 | 74.8 | 3.1 | 0.6 | 51.0 | 61.5 | 12.5 |
| USA | 3 | 301 | 72.9 | 57.5 | 9.3 | 9.0 | 13.0 | 70.9 | 3.2 | 0.6 | 60.1 | 71.8 | 27.6 |
| Denmark | 3 | 301 | 76.7 | 57.8 | 12.0 | 10.1 | 10.0 | 73.3 | 3.3 | 0.6 | 14.6 | 71.1 | 21.3 |
| Spain | 3 | 302 | 73.5 | 59.8 | 10.6 | 14.0 | 10.0 | 72.5 | 3.4 | 0.9 | 46.7 | 56.3 | 23.2 |
| France | 4 | 389 | 77.9 | 55.3 | 12.8 | 8.0 | 10.0 | 75.3 | 3.6 | 0.9 | 60.9 | 57.1 | 44.2 |
| Sweden | 3 | 260 | 71.8 | 59.4 | 12.5 | 12.0 | 10.0 | 81.6 | 3.6 | 0.9 | 41.2 | 65.8 | 26.9 |
| Ireland | 3 | 240 | 64.3 | 56.4 | 11.3 | 11.0 | 12.0 | 79.6 | 4.0 | 0.8 | 31.3 | 71.7 | 32.1 |
| Turkey | 3 | 309 | 85.6 | 51.9 | 11.6 | 12.0 | 5.0 | 67.6 | 4.1 | 0.9 | 57.3 | 69.3 | 5.8 |
| UK | 3 | 145 | 77.9 | 59.6 | 15.0 | 12.0 | 12.0 | 81.4 | 4.1 | 0.9 | 28.3 | 69.7 | 14.5 |
| Germany | 3 | 225 | 83.6 | 58.8 | 13.4 | 15.0 | 10.0 | 60.9 | 4.3 | 0.8 | 26.7 | 45.8 | 22.7 |
| Canada | 1 | 100 | 78.8 | 57.4 | 12.4 | 12.0 | 12.0 | 82.8 | 4.3 | 1.0 | 25.0 | 49.0 | 23.0 |
| Italy | 4 | 336 | 78.2 | 61.0 | 10.5 | 9.0 | 8.0 | 71.4 | 4.5 | 1.1 | 51.8 | 53.3 | 12.5 |
| Estonia | 3 | 168 | 85.5 | 55.8 | 11.8 | 12.0 | 12.0 | 68.1 | 4.7 | 1.1 | 40.5 | 53.6 | 0.6 |
| Latvia | 1 | 61 | 80.3 | 52.4 | 13.4 | 23.0 | 12.5 | 81.7 | 5.1 | 1.4 | 55.7 | 75.4 | 27.9 |
| Hungary | 3 | 153 | 87.4 | 57.9 | 12.6 | 12.0 | 12.0 | 92.8 | 5.2 | 1.4 | 38.6 | 62.7 | 12.4 |
| Poland | 7 | 642 | 86.7 | 53.2 | 11.5 | 4.0 | 12.0 | 70.3 | 5.3 | 1.4 | 58.9 | 65.0 | 6.1 |
| Lithuania | 2 | 300 | 82.9 | 54.1 | 10.7 | 13.0 | 13.0 | 78.4 | 5.6 | 1.4 | 80.7 | 55.7 | 9.3 |
| Argentina | 2 | 246 | 90.2 | 51.4 | 9.9 | 13.0 | 9.0 | 90.5 | 5.6 | 1.0 | 63.4 | 48.8 | 2.8 |
| Serbia | 1 | 100 | 88.0 | 59.2 | 10.1 | 11.1 | 8.0 | 71.4 | 6.1 | 1.6 | 54.0 | 54.0 | 0.0 |
| Total | 61 | 5,499 | 78.6 | 56.7 | 11.5 | 10.0 | 11.0 | 73.2 | 4.1 | 1.0 | 48.6 | 62.5 | 19.0 |
Modified and updated from [52], with permission